| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |